Erschienen in:
20.07.2023 | EDITORIAL
Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis?
verfasst von:
Leah A. John, MD, MBA, Usha B. Tedrow, MD, MSc, Sanjay Divakaran, MD
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 6/2023
Einloggen, um Zugang zu erhalten
Excerpt
Cardiac sarcoidosis (CS) is characterized by noncaseating granulomatous inflammation in the heart and can clinically present with conduction abnormalities, ventricular arrhythmia, congestive heart failure, and sudden cardiac death.
1 The diagnosis of CS remains challenging due to low yield of endomyocardial biopsy (EMB), which can be negative in up to 80% of patients.
2 A multimodality approach of cardiac magnetic resonance (CMR) imaging and cardiac
18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is often utilized for diagnosis. High-grade atrioventricular (AV) block can be the initial presentation of CS, and both the Heart Rhythm Society (HRS) expert consensus statement and Japanese Ministry of Health and Welfare (JMHW) guidelines include high-grade AV block as a clinical diagnostic criterion.
2,3 …